Tumor progression associated with erythropoiesis-stimulating agents.
about
The use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian cancer does not affect progression-free or overall survival.Thrombopoietin receptor levels in tumor cell lines and primary tumorsLow or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors.Casting doubt on the safety of "off-the-shelf" mesenchymal stem cells for cell therapy.Today's challenges in pharmacovigilance: what can we learn from epoetins?Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach
P2860
Q30453014-1B166B91-53AB-4642-B1E4-D609289F0674Q33394117-2F8F71AC-FE31-40BD-91EC-40D3BA61E192Q33403234-095A7922-1752-4ECE-9C82-E834850ADC5BQ33713210-2D3EF1F5-0479-435F-B33D-344041967C5DQ37854580-8B6AEA0F-05EF-402B-B7C3-AE4DA190F8F5Q50602023-F6BFB766-941E-4610-8890-5A5530DE2D1BQ57191817-C0EA147C-D6BD-46DF-BD47-A0C3C3DCF905
P2860
Tumor progression associated with erythropoiesis-stimulating agents.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Tumor progression associated with erythropoiesis-stimulating agents.
@en
Tumor progression associated with erythropoiesis-stimulating agents.
@nl
type
label
Tumor progression associated with erythropoiesis-stimulating agents.
@en
Tumor progression associated with erythropoiesis-stimulating agents.
@nl
prefLabel
Tumor progression associated with erythropoiesis-stimulating agents.
@en
Tumor progression associated with erythropoiesis-stimulating agents.
@nl
P2860
P356
P1476
Tumor progression associated with erythropoiesis-stimulating agents.
@en
P2093
Ashley M Newland
Curtis D Black
P2860
P304
P356
10.1345/APH.1L231
P407
P577
2008-11-18T00:00:00Z